ยท 3 days agoยท GeekWire
Eli Lilly invests $1.5 billion in Seattle biotech for advanced shingles vaccine
Eli Lilly agreed to acquire Bothell, Wash.-based Curevo Vaccine for up to $1.5 billion in cash. The deal centers on a next-generation shingles vaccine that reduced side effects by more than half in a Phase 2 study. Read More
#startups#biotech#vaccine-development#healthcare-innovation
